Second line, salvage and emerging treatments for HER2+ disease

Date 10 October 2016
Event ESMO 2016 Congress
Session HER2+ advanced breast cancer: A few more questions and many more answers
Topics Cytotoxic agents
Breast Cancer
Therapy
Biological therapy
Presenter Javier Cortes Castan
Authors J. Cortes Castan
  • Oncology, Hospital Universitario Ramon y Cajal, 28031 - Madrid/ES